AIM
OME

Alambic Investment Management’s Omega Protein OME Stock Holding History

Alambic Investment Management’s Portfolio OME Stock Details OME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-26,281
Closed -$438K – 576
2017
Q3 		$438K Sell
26,281
-52,019
-66% -$846K 0.05% 363
2017
Q2 		$1.4M Sell
78,300
-6,800
-8% -$127K 0.17% 202
2017
Q1 		$1.71M Buy
85,100
+65,200
+328% +$1.52M 0.21% 172
2016
Q4 		$498K Buy
19,900
+9,400
+90% +$222K 0.09% 333
2016
Q3 		$245K Buy
+10,500
New +$247K 0.06% 399
2016
Q2 		– Sell
-14,200
Closed -$241K – 620
2016
Q1 		$241K Buy
+14,200
New +$291K 0.08% 368

Alambic Investment Management's OME Position: Q4 2017 in Review

Alambic Investment Management sold out of Omega Protein (OME) in Q4 2017, closing a stake of 26,281 shares — an estimated $438K sold.

Alambic Investment Management first reported a position in OME in Q1 2016 and held it in 6 quarters. The position peaked at $1.71M in Q1 2017. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.

  • Alambic Investment Management reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
  • Alambic Investment Management sold 26,281 Omega Protein shares in Q4 2017, an estimated $438K.
  • Alambic Investment Management first reported a position in Omega Protein in Q1 2016 and held it in 6 quarters.
  • Alambic Investment Management's Omega Protein position peaked at $1.71M in Q1 2017.
  • 0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.

Based on Alambic Investment Management's 13F filing for Q4 2017, filed 2 Feb 2018.